In turn, Jacobs et al. demonstrated higher TRAP-, ADP-, and AA-stimulated platelet reactivity measured by whole blood aggregometry in COVID-19 compared with patients with other acute respiratory diseases [1]. This evidence concerns the gene CD40LG and COVID-19.